Schedule 13D ownership disclosure
SYROS PHARMACEUTICALS INC
Common Stock, $0.001 par value per share · CUSIP: 87184Q206
Event date: 2024-11-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Samsara BioCapital, L.P.Reported CIK 0001699737
Shares: 707,114.00 · Class: 2.6%
- Samsara BioCapital GP, LLCReported CIK 0001888829
Shares: 707,114.00 · Class: 2.6%
- Srinivas AkkarajuReported CIK 0001253170
Shares: 707,114.00 · Class: 2.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-009119
- Form type
- SCHEDULE 13D/A
- Filer
- Samsara BioCapital, L.P.
- CIK
- CIK 1699737
- Filed
- Mar 27, 2025
- Reporting period
- Nov 18, 2024
- Description
- Schedule 13D beneficial ownership